 HUTCHMED China Limited NASDAQ:HCM Q2 2022 Earnings Conference Call August 2, 2022 8:00 AM ET Company Participants Christian Hogg - Chief Executive Officer Hong Chen - Senior Vice President and Chief Commercial Officer, China Weiguo Su - Executive Director and Chief Scientific Officer Marek Kania - Executive Vice President, Managing Director and Chief Medical Officer, International Mark Lee - Senior Vice President, Corporate Finance Development Johnny Cheng - Executive Director and Chief Financial Officer Karen Atkin - Executive Vice President and Chief Operating Officer Simon To - Chairman, Executive Director, Hutchison China Meditech Ltd. Conference Call Participants Kelly Shi - Jeffries Paul Choi - Goldman Sachs Mike Mitchell - Panmure Gordon Yang Huang - Credit Suisse Matthew Yan - CLSA Operator Dr. Marek Kania, our Managing Director and Chief Medical Officer of HUTCHMED International. 